News Column

Midwestern University/Downers Grove Professor to Receive Prestigious Dawson Biotechnology Award

June 16, 2014



By a News Reporter-Staff News Editor at Clinical Trials Week -- The American Association of Colleges of Pharmacy will recognize a pharmacy educator from Midwestern University/Downers Grove for his contributions to contemporary teaching and scholarship in biotechnology. Anil Gulati, M.D., Ph.D., will receive the Paul R. Dawson Biotechnology Award during the Science Plenary at the AACP Annual Meeting, Pharmacy Education 2014, in Grapevine, Texas, July 26-30 (see also American Association of Colleges of Pharmacy).

"I'm so pleased to receive this award," Gulati said. "A lot of credit goes to my students who have contributed to my success and are now holding senior positions and making significant contributions in biotechnology."

Throughout his 35-year career, Gulati has made a lasting impact on student pharmacists, graduate students, postdoctoral researchers, medical fellows and colleagues. As professor and associate dean of research at Midwestern University Chicago College of Pharmacy, he developed a popular elective called Development of Newly Approved Drug Therapies. In this course, Gulati takes his students on a journey through the discovery, development and approval process of biotechnology products. He also teaches a required first-year course, Biopharmaceutics and Pharmacokinetics, in which students learn about the factors that influence the absorption, distribution, bioavailability and pharmacokinetic variability of biotechnology products.

"Dr. Gulati sets high standards for his students, and then coaches and guides them to achieving those standards," said Nancy Fjortoft, Ph.D., dean of the College of Pharmacy. "This truly exemplifies a great teacher."

Gulati is a nationally and internationally recognized expert in endothelin, which is a protein that constricts blood vessels and raises blood pressure. He has founded three pharmaceutical/biotechnology companies and as a result, some of his discoveries related to endothelin are undergoing clinical trials to translate into novel therapies in the areas of cancer treatment, neuroprotection, pain management and resuscitation from hemorrhagic shock. In 2007, Gulati received the International Ranbaxy Research Award and was a Fulbright Scholar in 2008-09.

The author of more than 285 peer-reviewed publications and recipient of 32 patents and inventions, Gulati says he is humbled to receive the Dawson award. He added, "It is a marvelous feeling to be listed among all those accomplished scientists and educators" who have previously received the award.

"From its inception the Dawson Award has recognized outstanding scientists who have worked at the frontier of so many important research areas. Dr. Gulati has certainly done this while engaging learners to fully integrate science into clinical education and practice." The 2014 AACP Annual Meeting will be held July 26-30 at the Gaylord Texan Resort and Convention Center. The conference offers educational programming, exhibits, networking events and award presentations. Registration fees are waived for credentialed journalists. Visit the AACP Web site or contact our media relations representative for more information. About AACP Founded in 1900, AACP is the national organization representing the interests of pharmacy education. AACP is comprised of all accredited colleges and schools with pharmacy degree programs, including more than 6,400 faculty, 62,500 students enrolled in professional programs and 5,100 individuals pursuing graduate study. To learn more about AACP, visit www.aacp.org.

Keywords for this news article include: Biotechnology, Clinical Trials and Studies, American Association of Colleges of Pharmacy.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Clinical Trials Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters